CIDRAP News: CDC’s adapted Ebola virus works in trials, as pressure for funds grows
“[Tuesday] researchers from the Centers for Disease Control and Prevention (CDC) published encouraging findings that showed the antiviral remdesivir and antibodies in the ZMapp treatment regimen were effective in fighting the current strain of Ebola. The findings were published in The Lancet Infectious Diseases. … In order to contain and ultimately end the current Ebola outbreak in the DRC’s North Kivu and Ituri provinces, the United States must fulfill its funding promise to the World Health Organization (WHO), and other nations must also take on the challenge of beating this disease. That’s the message of an editorial [Tuesday] in Nature…” (Soucheray, 7/10).

U.N. News: Mass measles vaccination campaign begins in Ebola-hit DR Congo province
“Health workers have started a massive measles vaccination campaign in north-east Democratic Republic of the Congo (DRC), a region that’s in the grip of the second deadliest Ebola virus outbreak on record. U.N. Children’s Fund UNICEF said on Thursday that it aims to inoculate 67,000 children in Ituri province…” (7/11).

Additional coverage of the DRC Ebola outbreak and response is available from Bloomberg and TIME.